Viveve to get US patent for technology to treat female stress urinary incontinence

Oct. 04, 2022 1:56 PM ETViveve Medical, Inc. (VIVE)By: Ravikash, SA News Editor

patented

Warchi

  • Viveve Medical (NASDAQ:VIVE) stock rose ~4% on Oct. 4 after the company said that the U.S. Patent and Trademark Office will issue a patent — application no. 16/454,578 — covering Viveve's dual-energy technology to treat female stress urinary incontinence (SUI).
  • The dual-energy

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.